[Twenty years of combination antiretroviral therapy for HIV infection in the Netherlands: progression and new challenges]

Ned Tijdschr Geneeskd. 2017;161:D1123.
[Article in Dutch]

Abstract

Due to the introduction of combination antiretroviral therapy (cART) 20 years ago, HIV infection in the Netherlands has changed from a fatal disease to a chronic condition with a near normalized life expectancy. The average age of HIV-positive patients continues to increase, as does the prevalence of non-HIV-related comorbidity. The number of new HIV diagnoses seems to be decreasing in the Netherlands, which is partly due to increased testing, earlier diagnosis, prompt cART initiation, and achievement of high levels of viral suppression, resulting in a reduced likelihood of onward transmission. In order to further curb the epidemic, it is important that as yet undiagnosed people living with HIV are identified as soon as possible. All practicing physicians in the Netherlands can contribute to this goal.

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Disease Progression
  • HIV Infections / drug therapy*
  • Humans
  • Life Expectancy
  • Netherlands

Substances

  • Anti-HIV Agents